Evercore ISI Adjusts Elevance Health Price Target to $430 From $440, Maintains In Line Rating

MT newswire2026/10/05 11:58

07:58 AM EDT, 10/05/2026 (MT Newswires) -- Elevance Health (ELV) has an average rating of overweight and mean price target of $446.52, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

MSCI adopts index exclusion rules that could oust Strategy

Cointelegraph•2026/10/16 01:00

Four hours ago, a whale opened the largest leverage long positions on bitcoin and ethereum, holding positions worth 187 millions dollars.

BlockBeats•2026/10/16 00:31

No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.

The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.

智通财经•2026/10/16 00:11

AiCoin丨10.16 Snapshot: PPI Exceeds Expectations, Russia Bans P2P, US Stock ETF Net Outflow

AiCoin•2026/10/16 00:03